ORLANDO — In this video from the American Academy of Ophthalmology meeting, David A. Eichenbaum, MD, FASRS, discusses phase 2b ASPIRE study results comparing UBX1325 vs. aflibercept in patients with diabetic macular edema.In the phase 2b study, researc…
More than half of patients with moderate-to-severe thyroid eye disease who do not improve with corticosteroids achieve disease control after 6 months of treatment with tocilizumab. Medscape Medical News
GENEVA–(BUSINESS WIRE)–Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds
GENEVA–(BUSINESS WIRE)–Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds
Early diagnosis of reactive infectious mucocutaneous eruption is important to minimize potential long-term disease complications. Medscape Medical News
Dr Sunir Garg explores how AI is transforming retinal care, from individualized treatments to tracking disease progression and bridging gaps across specialties. Medscape